SCHEMBL17015189

SCHEMBL17015189

c1ccc(-n2ccc3c2ccc2c4ccccc4n(-c4cccc(-c5cc6ccccc6c6ccccc56)c4)c23)cc1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP11B1 P15538 1/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
GAA P10253 1/20 0.31
POLB P06746 1/20 0.30
CTDSP1 Q9GZU7 1/20 0.30
DUSP3 P51452 1/20 0.30
ALOX5 P09917 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
MPI P34949 1/20 0.30
WNK1 Q9H4A3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015653 0.97 KDM4E (0.32) KDM4EATML3MBTL1CYP11B1WNK1
SCHEMBL17016133 0.96 L3MBTL1 (0.37) KDM4EATML3MBTL1CYP11B1MEN1
SCHEMBL17015733 0.95 KDM4E (0.32) KDM4EATML3MBTL1CYP11B1WNK1
SCHEMBL17015190 0.90 KDM4E (0.38) KDM4EATML3MBTL1CYP11B1MEN1
SCHEMBL17016135 0.90 KDM4E (0.38) KDM4EATML3MBTL1CYP11B1MEN1
SCHEMBL17015180 0.89 KDM4E (0.34) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17015650 0.89 GPR84 (0.34) KDM4EATML3MBTL1CYP11B1MEN1
SCHEMBL17015201 0.89 KDM4E (0.36) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL15632449 0.88 L3MBTL1 (0.41) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL15684055 0.87 ATM (0.40) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 KDM4E 1286/4885ATM 3623/4885L3MBTL1 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.